| Pharmaceutical active ingredients: |
| CasanthranolDocusate Sodium |
| Available forms, composition and doses of Silace-C: |
| N / A |
| Silace-C medical category: |
| Human:Cathartics and laxatives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A06AB57 - Cascara, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Silarx Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Sil Trax plus No. 8 | Epinephrine Hydrochloride Racemic; Zinc Phenolsulphonate | Pascal International Corporation |
| Sil Trax plus No. 9 | Epinephrine Hydrochloride Racemic; Zinc Phenolsulphonate | Pascal International Corporation |
| SIL-1000 | Silicone Oil | Dutch Ophthalmic Research Center |
| SIL-5000 | Silicone Oil | Dutch Ophthalmic Research Center |
| Silace | Docusate Sodium | Silarx Pharmaceuticals; Tanta Pharmaceuticals |
| SilaClean 20 / 20 | Solution for Hard Contact Lenses | SoftRinse Corporation |
| Silact | Tilactase | Sofar Farmaceutici |
| Siladryl | Diphenhydramine Hydrochloride | Silarx Pharmaceuticals |
| Silafed | Pseudoephedrine Hydrochloride; Triprolidine Hydrochloride | Silarx Pharmaceuticals |
| Silagra | Sildenafil Citrate | Cipla |